Actively Recruiting
Clinical and Imaging Cohort of Neuroinflammation Diseases in China (CLUE)
Led by Beijing Tiantan Hospital · Updated on 2024-12-24
1000
Participants Needed
1
Research Sites
521 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
CLUE is a prospective study to determine structural and functional changes of brain and spinal cord, as well as the inflammatory environment in patients with neuroinflammatory and demyelination disease. Participants will receive new magnetic resonance (MR) technics including double inversion recovery (DIR) imaging diffusion kurtosis imaging (DKI), quantitative susceptibility mapping (QSM) and resting-state functional imaging and follow up for one year using 3T MRI. In addition, participants will receive T1WI, T2WI, FLAIR and SWI sequences on 7T MRI.
CONDITIONS
Official Title
Clinical and Imaging Cohort of Neuroinflammation Diseases in China (CLUE)
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age between 16 and 75 years
- Diagnosis of neuroinflammatory and demyelination disease
- Availability of demographic and clinical data at disease onset
- Informed written consent obtained from patient or legal representative; assent if under 16 years old
You will not qualify if you...
- Contraindication for MRI
- Participation in an ongoing blinded clinical trial
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Beijing Tiantan Hospital
Beijing, Beijing Municipality, China, 100053
Actively Recruiting
Research Team
Y
Yaou Liu, PhD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
4
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here